105 related articles for article (PubMed ID: 23104349)
1. Gene gun immunization to combat malaria.
Bergmann-Leitner ES; Leitner WW
Methods Mol Biol; 2013; 940():269-84. PubMed ID: 23104349
[TBL] [Abstract][Full Text] [Related]
2. Biolistic DNA vaccination against Trypanosoma infection.
Bryan M; Guyach S; Norris KA
Methods Mol Biol; 2013; 940():305-15. PubMed ID: 23104351
[TBL] [Abstract][Full Text] [Related]
3. Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite.
Yoshida S; Kashiwamura SI; Hosoya Y; Luo E; Matsuoka H; Ishii A; Fujimura A; Kobayashi E
Biochem Biophys Res Commun; 2000 Apr; 271(1):107-15. PubMed ID: 10777689
[TBL] [Abstract][Full Text] [Related]
4. Vaccination Using Gene-Gun Technology.
Bergmann-Leitner ES; Leitner WW
Methods Mol Biol; 2015; 1325():289-302. PubMed ID: 26450396
[TBL] [Abstract][Full Text] [Related]
5. Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein.
Weiss R; Leitner WW; Scheiblhofer S; Chen D; Bernhaupt A; Mostböck S; Thalhamer J; Lyon JA
Infect Immun; 2000 Oct; 68(10):5914-9. PubMed ID: 10992502
[TBL] [Abstract][Full Text] [Related]
6. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
7. Effects of DNA vaccine in murine malaria using a full-length cDNA library.
Shibui A; Ohmori Y; Suzuki Y; Sasaki M; Nogami S; Sugano S; Watanabe J
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):147-57. PubMed ID: 11758646
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of C3d on the immunogenicity of gene gun vaccines encoding Plasmodium falciparum and Plasmodium berghei MSP1(42).
Weiss R; Gabler M; Jacobs T; Gilberger TW; Thalhamer J; Scheiblhofer S
Vaccine; 2010 Jun; 28(28):4515-22. PubMed ID: 20438877
[TBL] [Abstract][Full Text] [Related]
9. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites.
Leitner WW; Seguin MC; Ballou WR; Seitz JP; Schultz AM; Sheehy MJ; Lyon JA
J Immunol; 1997 Dec; 159(12):6112-9. PubMed ID: 9550412
[TBL] [Abstract][Full Text] [Related]
10. Biolistic DNA vaccination against melanoma.
Steitz J; Tüting T
Methods Mol Biol; 2013; 940():317-37. PubMed ID: 23104352
[TBL] [Abstract][Full Text] [Related]
11. Identification of T cell epitopes of Mycobacterium tuberculosis with biolistic DNA vaccination.
Nagata T; Koide Y
Methods Mol Biol; 2013; 940():285-303. PubMed ID: 23104350
[TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS.
Bergmann-Leitner ES; Legler PM; Savranskaya T; Ockenhouse CF; Angov E
Vaccine; 2011 Aug; 29(35):5940-9. PubMed ID: 21722682
[TBL] [Abstract][Full Text] [Related]
13. Screening of novel malaria DNA vaccine candidates using full-length cDNA library.
Shibui A; Nakae S; Watanabe J; Sato Y; Tolba ME; Doi J; Shiibashi T; Nogami S; Sugano S; Hozumi N
Exp Parasitol; 2013 Nov; 135(3):546-50. PubMed ID: 24055215
[TBL] [Abstract][Full Text] [Related]
14. Efficiency of biolistic DNA vaccination in experimental type I allergy.
Raker V; Maxeiner J; Reske-Kunz AB; Sudowe S
Methods Mol Biol; 2013; 940():357-70. PubMed ID: 23104354
[TBL] [Abstract][Full Text] [Related]
15. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
Hoffman SL; Doolan DL
Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
[TBL] [Abstract][Full Text] [Related]
16. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
17. Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis.
Bergmann-Leitner ES; Leitner WW; Duncan EH; Savranskaya T; Angov E
Vaccine; 2009 Sep; 27(41):5700-8. PubMed ID: 19576940
[TBL] [Abstract][Full Text] [Related]
18. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Reyes-Sandoval A; Sridhar S; Berthoud T; Moore AC; Harty JT; Gilbert SC; Gao G; Ertl HC; Wilson JC; Hill AV
Eur J Immunol; 2008 Mar; 38(3):732-41. PubMed ID: 18266272
[TBL] [Abstract][Full Text] [Related]
19. Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force.
Tyagi RK; Garg NK; Sahu T
J Control Release; 2012 Aug; 162(1):242-54. PubMed ID: 22564369
[TBL] [Abstract][Full Text] [Related]
20. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
